Explore the Global Antiviral Immunoglobulin Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Antiviral Immunoglobulin Market

Key Insight

Antiviral immunoglobulin sales will expand through 2036, with intravenous immunoglobulin holding 52.0% of the product type segment in 2026, driven by standardized treatment protocols and established clinical procurement patterns. The market is projected to reach USD 5.5 billion in 2026 and USD 10.08 billion by 2036, creating an incremental opportunity of USD 4.56 billion.

May 08, 2026

Anurag Sharma

240 Pages

Cite this Report

Antiviral Immunoglobulin Market

https://www.futuremarketinsights.com/reports/antiviral-immunoglobulin-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Bharat Serums
Biotest AG
CSL Behring
China Biologic Products Holdings Inc
Emergent BioSolutions Inc
Grifols S.A
Kamada Ltd
Kedrion Biopharma Inc
Octapharma AG
Shanghai RAAS Blood Products Co. Ltd
Vaccines Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Antiviral Immunoglobulin Market

Key Players

Similar Industry Reports